Firefly Neuroscience (NASDAQ:AIFF) Posts Earnings Results

Firefly Neuroscience (NASDAQ:AIFF) released its quarterly earnings results on Wednesday. The company reported ($0.20) earnings per share for the quarter, FiscalAI reports. Firefly Neuroscience had a negative net margin of 5,335.75% and a negative return on equity of 464.02%. The business had revenue of $0.39 million during the quarter.

Firefly Neuroscience Stock Performance

NASDAQ:AIFF traded down $0.10 during trading hours on Friday, reaching $1.50. The stock had a trading volume of 187,837 shares, compared to its average volume of 3,448,092. Firefly Neuroscience has a 52 week low of $1.48 and a 52 week high of $17.20. The stock has a market capitalization of $20.17 million, a PE ratio of -0.60 and a beta of 2.14. The company has a 50 day moving average price of $2.47 and a two-hundred day moving average price of $2.81.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Firefly Neuroscience in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of “Sell”.

Insider Buying and Selling

In other Firefly Neuroscience news, major shareholder Windsor Private Capital Lp sold 78,031 shares of the stock in a transaction on Wednesday, October 22nd. The stock was sold at an average price of $2.07, for a total transaction of $161,524.17. Following the sale, the insider owned 1,236,773 shares of the company’s stock, valued at approximately $2,560,120.11. This trade represents a 5.93% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have sold a total of 400,000 shares of company stock valued at $1,015,775 over the last ninety days. Insiders own 6.44% of the company’s stock.

Hedge Funds Weigh In On Firefly Neuroscience

Institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in Firefly Neuroscience by 393.3% during the 3rd quarter. Vanguard Group Inc. now owns 503,071 shares of the company’s stock worth $1,464,000 after acquiring an additional 401,085 shares in the last quarter. Geode Capital Management LLC boosted its stake in Firefly Neuroscience by 92.9% in the second quarter. Geode Capital Management LLC now owns 120,604 shares of the company’s stock valued at $341,000 after acquiring an additional 58,067 shares in the last quarter. Finally, Savvy Advisors Inc. acquired a new stake in shares of Firefly Neuroscience in the 3rd quarter valued at about $63,000. 4.96% of the stock is owned by hedge funds and other institutional investors.

About Firefly Neuroscience

Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.